Bulletin from Elekta’s Annual General Meeting 2015

STOCKHOLM, September 1, 2015 – The Annual General Meeting adopted the following
resolutions:

Dividend and appropriation of the Company’s profits
Of the Company’s unappropriated earnings totalling SEK 1,971,134,244, a per
-share dividend of SEK 0.50 to be distributed to shareholders. The remaining
amount is to be carried forward. The record date for the dividend was set at
Thursday, September 3, 2015 and the payment is expected to be made on Tuesday,
September 8, 2015.
Adoption of the income statement and balance sheet
The meeting adopted the income statement and balance sheet for the Parent
Company, as well as the consolidated income statement and consolidated balance
sheet as of April 30, 2015. The members of the Board and the former CEO Niklas
Savander were discharged from liability for fiscal year 2014/15.

Board of Directors and committees
The meeting resolved that the Board of Directors is to comprise nine members
without deputies. Luciano Cattani, Laurent Leksell, Siaou-Sze Lien, Tomas
Puusepp, Wolfgang Reim, Jan Secher and Birgitta Stymne Göransson were reelected
as members of the Board. Annika Espander Jansson and Johan Malmqvist were
elected as new members of the Board. Hans Barella declined reelection. Laurent
Leksell was reelected as Chairman of the Board.

The following director fees were adopted: SEK 1,075,000 (1,040,000) to the
Chairman of the Board, SEK 460,000 (445,000) to each external member of the
Board, SEK 90,000 (unchanged) to the Chairman and SEK 50,000 (unchanged) to
other members of the Company’s Remuneration Committee, SEK 200,000 (unchanged)
to the Chairman and SEK 110,000 (unchanged) to other members of the Company’s
Audit Committee. No Company-employed Board Members are to receive remuneration
or compensation for Committee work.

Before the end of the second quarter of the fiscal year, the Chairman of the
Board is to appoint a Nomination Committee by contacting representatives of the
four largest holders of voting rights at the last banking day in September,
besides the or those shareholders the Chairman of the Board may represent, which
may appoint one person each that, together with the Chairman of the Board, shall
constitute the Nomination Committee until the end of the next Annual General
Meeting, or, where applicable, until a new Nomination Committee has been
appointed.

Auditors
The meeting reelected the registered public auditing firm PwC, with auditor-in
-charge Johan Engstam, as auditor for the period until the close of the 2016
Annual General Meeting. Fees will be paid according to an approved account.

Guidelines for remuneration of senior executives
The Meeting approved the guidelines for remuneration and other employment
conditions for senior executives. The guidelines apply for employment contracts
that become effective after the Meeting’s resolution and in the event that
changes are made to existing contracts after this date.

Performance Share Plan 2015
The Meeting resolved to adopt Performance Share Plan 2015. The program comprises
the President and the CEO and Executive Management in the Company, in total
eleven (11) employees including the President and CEO, who will qualify for
allotment, free of charge, of Elekta B-shares following expiry of the three year
performance period and provided continued employment during the performance
period. The total number of shares that can be allotted depends on the degree of
fulfilment of one financial target, EPS Growth over a 3-year Performance Period.
The award will vest if the compound annual growth rate of EPS is between 32 per
cent and 41 per cent comparing 2017 financial results to 2014. The performance
target shall be adjusted at the occurrence of events affecting the number of
outstanding shares in the Company, or unforeseen material events affecting the
Elekta Group´s operations or otherwise affecting the performance targets and
deemed relevant by the Board of Directors. Should the Company decide on changes
to the Company’s accounting principles or decide on restructuring costs the
Board may decide on changes to the Performance Share Plan 2015 performance
targets. Assuming maximum allotment under the Performance Share Plan 2015 and a
share price of SEK 50, a maximum of 421,200 series B shares are required to
fulfil commitments under the program (including social security costs),
corresponding to approximately 0.11 per cent of the total number of outstanding
shares, and the costs, including social security costs and the financing cost
for repurchased own shares, are estimated at approximately SEK 21,060,000.

Acquisition and transfer of own shares
The Meeting authorized the Board of Directors, during the period until the next
Annual General Meeting to resolve, on one or more occasions, on the acquisition
of a maximum number of own shares so that, after the acquisitions, the Company
does not hold more than five per cent of the total number of shares in the
Company. The Meeting also authorized the Board of Directors, during the period
until the next Annual General Meeting to resolve, on one or more occasions, on
transfers of own shares in connection with financing takeovers and other
strategic investments and transfers, and not exceeding the maximum number of
treasury shares held by the Company at any given time.

In view of the Performance Share Plan 2015, the Meeting resolved to approve the
transfer of treasury shares amounting to not more than 475,000 shares of series
B, and to authorize the Board of Directors, during the period until the next
Annual General Meeting, on one or more occasions, to make decisions that not
more than 142,500 shares will be transferred on Nasdaq Stockholm with the
purpose of covering certain fees, primarily social security costs.

In view of the Performance Share Plan 2014, the Meeting resolved to approve the
transfer of treasury shares amounting to not more than 1,139,600 shares of
series B.

In view of the Performance Share Plan 2013 and 2014, the Meeting authorized the
Board of Directors during the period until the next Annual General Meeting, on
one or more occasions, to make decisions that not more than 286,800 shares will
be transferred on Nasdaq Stockholm with the purpose of covering certain fees,
primarily social security costs.

# # #

For further information, please contact:
Johan Andersson, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, e-mail: johan.andersson@elekta.com
Time zone: CET: Central European Time
The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial Instruments
Trading Act. The information was published at 16:15 CET on September 1, 2015.
About Elekta
Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing
software systems across the spectrum of cancer care. Stretching the boundaries
of science and technology, providing intelligent and resource-efficient
solutions that offer confidence to both health care providers and patients,
Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,800 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on the Nordic Exchange under the ticker STO:EKTAB. Website:
www.elekta.com.